ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Gsk Plc

Gsk Plc (GSK)

1 306,50
6,50
( 0,50% )
Mis à jour : 09:27:46

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
1 306,50
Prix Achat
1 305,50
Prix Vente
1 306,00
Volume échangé
228 464
1 300,00 Fourchette du Jour 1 309,50
1 282,50 Plage de 52 semaines 1 820,00
Cap du marché
Clôture Veille
1 300,00
Ouverture
1 300,00
Dernière Transaction
16
@
1306
(O)
Dernière heure de transaction
09:27:32
Volume financier
2 980 727p
VWAP
1 304,6812
Volume moyen (3 m)
8 420 977
Actions en circulation
4 145 087 815
Rendement du Dividende
4.59%
Ratio Cours sur Bénéfices
11,01
Bénéfice par action (BPA)
1,19
Chiffre d'affairess
30,33B
Bénéfice net
4,93B

À propos de Gsk Plc

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
London, Gbr
Fondé
-
Gsk Plc est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker GSK. Le dernier cours de clôture d'Gsk était de 1 300,00p. Au cours de la dernière année, les actions de Gsk ont été négociées dans une fourchette de prix de 1 282,50p à 1 820,00p.

Gsk compte actuellement 4 145 087 815 actions en circulation. La capitalisation boursière d'Gsk est de £53,89 milliard. Gsk a un ratio cours/bénéfice (ratio PE) de 11.01.

GSK Dernières nouvelles

GSK PLC Director/PDMR Shareholding

GSK PLC 19 November 2024   GSK plc (the 'Company')   Transaction notification     1. Details of PDMR/person closely associated with them ('PCA') a) Name Dr Hal Barron b) Position/status...

GSK hails positive results for linerixibat in treating relentless itch

GSK PLC on Tuesday said that its investigational targeted inhibitor linerixibat demonstrated sound results for a trea ...

GSK PLC GLISTEN Trial of Linerixibat Meets Endpoint

GSK PLC 19 November 2024   Issued: 19 November 2024, London UK    Linerixibat shows positive Phase III results in cholestatic pruritus (relentless itch) in primary biliary cholangitis (PBC...

GSK hails survival results in blood cancer patients with Blenrep

GSK PLC on Thursday said its Blenrep drug has shown overall survival benefits in patients with relapsed or refractory ...

GSK PLC GSK announces overall survival results for Blenrep

GSK PLC 14 November 2024   Issued: 14 November 2024, London UK   Blenrep shows overall survival benefit in head-to-head DREAMM-7 phase III trial for relapsed/refractory multiple myeloma   ·  ...

GSK PLC Block listing Interim Review

GSK PLC 13 November 2024         BLOCK LISTING SIX MONTHLY RETURN     Date: 13 November 2024   Name of applicant: GSK plc Name of scheme: GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan...

GSK PLC Director/PDMR Shareholding

GSK PLC 12 November 2024   GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

GSK PLC GSK publishes provisional 2025 dividend dates

GSK PLC 11 November 2024   GSK plc   GSK publishes provisional dividend dates     GSK announces the following dividend dates for 2025:     These dates are indicative and may be subject to...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-47-3.472478758771353.51364.51282.5122751921310.61943585DE
4-151-10.36020583191457.51462.51282.5102836301375.12499315DE
12-356-21.41353383461662.516781282.584209771477.38240893DE
26-463.5-26.18644067817701808.51282.580003861536.01672936DE
52-94.9-6.771799628941401.418201282.578347901568.61907528DE
156-221.5-14.496073298415281824.41282.586589761532.92443754DE
260-403.1-23.57861488071709.618571190.888469451513.76675056DE

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
CRTMCritical Metals Plc
1,20p
(20,00%)
302
FARFerro-alloy Resources Limited
2,75p
(17,02%)
1,44M
STXShield Therapeutics Plc
3,125p
(16,82%)
8,53M
RCGHRc365 Holding Plc
1,45p
(16,00%)
1,31M
RRRRed Rock Resources Plc
0,05p
(11,11%)
10,2M
NTOGNostra Terra Oil And Gas Company Plc
0,0235p
(-37,33%)
229,15M
SLFRSlf Realisation Fund Limited
1,02p
(-27,66%)
6,78k
QUIZQuiz Plc
4,12p
(-21,52%)
8,53k
PPSProton Motor Power Systems Plc
0,145p
(-19,44%)
373,58k
PRMProteome Sciences Plc
2,30p
(-16,36%)
12,02k
NTOGNostra Terra Oil And Gas Company Plc
0,0235p
(-37,33%)
229,15M
NTVONativo Resources Plc
0,0023p
(0,00%)
118,56M
UKOGUk Oil & Gas Plc
0,02475p
(0,00%)
19,02M
SYNSynergia Energy Ltd
0,049p
(0,00%)
15,86M
SYMESupply@me Capital Plc
0,00325p
(0,00%)
13,93M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock